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We previously showed (18) that small intestinal DTH responses to the contact sensitizer 2,4-dinitro-1-fluorobenzene (DNFB) in the rat were characterized by an inflammatory response, intestinal mucosal mast cell activation, and tissue accumulation of mucosal mast cells 48-72 h after local challenge. In addition, pharmacological manipulation of the mucosal mast cell before and at time of challenge, either by depletion or stabilization, was very effective in reducing the DTH-specific increase in small intestinal vascular leakage and mucosal mast cell degranulation found at 48 h (20) . Using mast cell-deficient mice, we demonstrated (21) that mast cells contribute significantly to changes in vascular permeability associated with small intestinal DTH reaction. These results suggested that the mucosal mast cell is an important cell in the initiation of contact sensitizer-induced DTH reactions in the small intestine of the rat.
Sensory neurons densely innervate the gastrointestinal tract and are found in close association with lymphocytes and mucosal mast cells (3, 8, 33, 34) . The effects of neuropeptides on immunologic functions involved in DTH reactions are clearly described: directly via lymphocyte proliferation, maturation, and activation and indirectly via activation of mucosal mast cell or via effects on the vascular endothelium (30, 32) . Substance P has the ability to activate mucosal mast cells, and substance P-induced inflammatory responses are shown to be mast cell dependent (12, 37) . Moreover, we have demonstrated that sensory nerves are involved in the development of dinitrobenzene-induced small intestinal DTH reactions in the mouse (17) . The results were consistent with an initiating role of sensory neuropeptides, especially tachykinins, in dinitrobenzene-induced intestinal DTH reactions.
The relevant biological actions together with the close association between mast cells and sensory nerves in the gastrointestinal tract suggest a possible function for mast cell-sensory nerve interaction in the early component of DTH reactions. Taking the abovedescribed studies together, it can be postulated that at the time of challenge the mucosal mast cell is activated via sensory neuropeptides. This early phase process is necessary for the development of the late-phase inflammatory reaction (edema formation, tissue damage, and mucosal mast cell activation and accumulation). In the present study, the role of mucosal mast cells in the early phase of the dinitrobenzene-induced DTH reaction in the rat small intestine was examined in detail. First, we investigated whether mucosal mast cells are activated shortly after the challenge. Rat mast cell protease II (RMCP II), a unique protease located within the granules of intestinal mucosal mast cells, was used as a serum marker for mast cell degranulation. Second, we examined whether this mucosal mast cell activation leads to early phase vascular permeability changes, which in turn facilitate the entry into the tissue of classical DTH effector cells. The vascular permeability changes were studied from 0 to 1 h after the challenge both in vivo and in vitro in the isolated vascularly perfused small intestine (19) . The effects of the mast cell stabilizer doxantrazole on the early DTH-induced changes in small intestinal vascular permeability and RMCP II serum levels were investigated in vivo. Finally, to investigate whether the DTH-induced mucosal mast cell activation and early phase vascular permeability changes were under sensory nervous control, the influence of capsaicin-sensitive nerves on the early phase events of the small intestinal DTH response were studied. Neonatal pretreatment with capsaicin was used to deplete sensory neuropeptides. The effect of this neuropeptide depletion was examined in vivo on DTHinduced changes in small intestinal vascular permeability and mucosal mast cell activation observed early after the challenge.
METHODS
Male Wistar rats (Utrecht ϫ Wistar Unilever, 200-250 g; Utrecht University, Utrecht, The Netherlands) that had free access to food (Rmh-tm-11/10; Hopefarm, Woerden, The Netherlands) and tapwater were used. The experiments were approved by the Animal Care Committee of Utrecht University.
Sensitization and challenge procedure. DNFB (5 mg/ml, 300 µl) or vehicle (acetone/olive oil, 4:1, 300 µl) was applied epicutaneously to the shaven dorsal skin of anesthetized rats (60 mg/kg body wt pentobarbital sodium; Nembutal, Sanofi, France; n ϭ 5/group) on day 0 and day 1. On day 5, the animals, which were previously fasted for 16 h, were challenged with an intragastric administration of dinitrobenzene sulfonic acid (DNBS, the water-soluble form of DNFB; 1 mg/ml, 1 ml) or vehicle (1 ml saline). DNFB and olive oil were purchased from Sigma Chemical (St. Louis, MO). DNBS was purchased from Eastman Kodak (Rochester, NY).
All animals used in this study, except those involved in the in vitro vascular permeability study, received a topical challenge on one ear with DNFB (2 mg/ml, 40 µl). Skin reactions demonstrated that all rats sensitized with DNFB developed an ear swelling response to topical DNFB challenge. From this, we concluded that the animals were sufficiently sensitized to DNFB.
Treatment of experimental animals. To investigate the effect of mucosal mast cell stabilization, doxantrazole (10 mg/kg body wt doxantrazole monohydrate; a gift from Wellcome, Beckenham, Kent, UK) or vehicle [0.5% sodium bicarbonate (Sigma Chemical) in sterile saline] was injected intraperitoneally (1 ml). The doxantrazole treatment was applied 30 min before and at the time of challenge. This procedure was followed to be sure that at the time of challenge a sufficiently high amount of doxantrazole was present in the rats to stabilize mucosal mast cells in the small intestine. The dose and the route of administration were obtained using the method of Perdue and Galli (28) .
Capsaicin (Fluka Chemika, Buchs, Switzerland) was used to deplete neuropeptides from unmyelinated sensory C fibers. Neonatally, rats pretreated with the analgetic agent flunixine (1 mg/kg body wt ip) received subcutaneous injections of capsaicin (50 mg/kg body wt) on 2 consecutive days. Controls were treated with vehicle (alcohol/Tween 80/saline, 2:1:7) alone. The rats were used 6-7 wk after pretreatment with capsaicin (body wt, 200-225 g). The degree of sensory neuropeptide depletion was checked by verifying that in vitro capsaicin-induced relaxations of isolated carbachol-precontracted tracheas of the capsaicin-pretreated rats were reduced to Ͻ10% of control values of tracheas of vehiclepretreated rats.
In vivo small intestinal vascular leakage. To assess vascular leakage in the small intestine in vivo, Evans blue dye (20 mg/kg body wt in sterile saline; Fluka Chemika) was injected intravenously into anesthetized animals (60 mg/kg body wt pentobarbital sodium) 30 min after the challenge. Heparin (1,000 IU/rat; Leo Pharmaceutical Products, Ballerup, Denmark) was administered intravenously 5 min before the rats were killed. At t ϭ 60 min, the animals were killed (with an overdose of pentobarbital sodium) and a blood sample was taken. The intestines were perfused with warm saline (30 ml) to eliminate the excess of vascular Evans blue. Perfusion was performed via cardiac puncture, and the perfusate was allowed to depart via a cut vein in the hind paw. Accumulated Evans blue dye in the small intestine was extracted overnight using formamide (Merck, Darmstadt, Germany) at 40°C. Evans blue dye (in µg) in extracts and plasma samples was determined using a spectrophotometer (double-beam spectrophotometer UV 150-02, Shimadzu) at 620 nm (38). Over the time interval of 30-60 min after the challenge, the small intestinal vascular leakage was measured. The amount of Evans blue was expressed as nanograms of Evans blue per milligrams of small intestinal dry weight and corrected for the plasma concentration (ng Evans blue/mg dry wt). The dry weight of the pieces of small intestine was determined by drying the parts in a stove at 60°C for ϳ10 days. If no changes in weight occurred over the 2 following days, this weight was taken as the dry weight.
In vitro small intestinal vascular permeability changes. In vitro assessment of vascular permeability was measured in the isolated vascularly perfused small intestine. On day 5 the entire small intestine from DNFB-or sham-sensitized rats was isolated as described previously (19) . Briefly, after cannulation of the superior mesenteric artery and the portal vein, the vascular bed was perfused with medium. This medium consisted of a buffered salt solution containing 20% (wt/vol) perfluorotributylamine (FC-43; 3M, Leiden, The Netherlands), 2.46% (wt/vol) poly(propylene glycol):polyethylene glycol (1:4) (Synperonic F-68; Sevra Feinbiochemica, Heidelberg, Germany), 103 mM NaCl, 4.56 mM KCl, 1 mM MgCl 2 , 1.9 mM CaCl 2 , 25 mM NaHCO 3 , 10 mM glucose, 1% (wt/vol) albumin, and 0.6 mM glutamine and was gassed with 95% O 2 -5% CO 2 . Perfusion through the vascular bed was recirculated at a rate of 5 ml/min. The lumen was perfused single pass at a rate of 0.5 ml/min. The luminal perfusate was a 0.9% NaCl solution. The small intestine was excised and transferred to a tissue bath, which was kept at 37°C. Thirty minutes after the intestine was isolated, the luminal perfusate was changed to a solution of DNBS (1 mg/ml in 0.9% NaCl) for in vitro challenge of the preparation. Four tracer injections were administered 0 (i.e., before DNBS challenge), 15, 30, and 60 min (i.e., after DNBS challenge) after the start of the DNBS infusion. The following tracers were studied: tetramethylrhodamine-conjugated dextran (TMRD3; 3.0 kDa, 0.03 mg/ml), Cascade blue-conjugated dextran (CBD10; 10 kDa, 0.10 mg/ ml), Texas red-conjugated dextran (TRD70; 70 kDa, 0.27 mg/ml), and FITC-conjugated Ficoll (FF400; 400 kDa, 0.27 mg/ml) (Molecular Probes, Eugene, OR). All compounds were dissolved in the vascular perfusate. After the perfusion through the vascular bed was changed from recirculating to single pass, a mixture of the four tracers (200 µl) was injected rapidly into the arterial cannula and total venous drainage was collected in a series of 10 tubes (ϳ300 µl each). The venous samples were weighed to determine volume and collection time. After centrifugation (10 min at 15,000 g max ) the concentrations of the four tracers in the supernatants were measured fluorometrically in a 96-well plate reader (LS50B; Perkin Elmer, Gouda, The Netherlands) with TMRD3 at 555/580 nm, CBD10 at 400/425 nm, TRD70 at 591/612 nm, and FF400 at 495/520 nm for excitation and emission wavelength, respectively.
Pharmacokinetic analysis, based on statistical moment theory, of the tracer (i) outflow concentration-time curve was used to assess vasopermeability: extraction ratios (E i ), volumes of distribution (V d,i ), and intrinsic clearance values (Cl int,i ). This involves analysis of the complete venous outflow concentration-time curve (dilution curve). The outflow concentrations of the tracers were normalized by expressing the concentration in each sample relative to the concentration in the original injectate (C i ). Subsequently, a relative concentration-time outflow curve was obtained for each tracer used.
The first two moments of the relative concentration-time curve of each tracer on a single pass through the isolated vascularly perfused small intestine were determined for the calculation of the area under the concentration-time curve (AUC i ) and the mean transit time (t i ). AUC i ϭ ͐C i dt t i ϭ (͐tC i dt)/AUC i A vascular tracer (vrs) is a tracer that is not eliminated and retained in the intravascular space. Thus, theoretically, the extraction of a vascular tracer is 0. The extraction ratio for diffusible tracers was calculated by
where AUC vrs is the area under the concentration-time curve of the vascular tracer.
The intrinsic clearance (in ml/min) according to the parallel tube model is calculated by
where Q is the perfusate flow rate.
The volume of distribution of each tracer (V d,i ) is calculated (in ml) from the intrinsic clearance by V d,i ϭ Cl int,i ϫ t i /E i All the data are expressed as either a percentage (E i ), in milliliters (V d,i ), or in milliliters per minute (Cl int,i ) per small intestine.
Measurement of RMCP II. The sera were collected via orbital puncture in the anesthetized rats (sham/DNBS and DNFB/DNBS) 15, 30, and 60 min after the challenge, and the samples were snap frozen in liquid nitrogen and stored at Ϫ80°C. From a separate group of nonsensitized and nonchallenged (naive) rats, serum samples were collected at t ϭ 0, 15, 30, and 60 min. The RMCP II ELISA (Moredun Animal Health, Edinburgh, UK) was used for measurements of RMCP II in the serum of the groups of rats described above. The results were expressed as nanograms of RMCP II per milliliter of serum.
Data analysis. Results are presented as means Ϯ SE. Data were analyzed by ANOVA, and the statistical significance of difference between means was determined using the Newman-Keuls test. P Ͻ 0.05 was considered to reflect a statistically significant difference.
RESULTS
In vivo small intestinal vascular leakage. Figures 1  and 2 demonstrate that 30-60 min after challenge in vivo a significant increase in small intestinal vascular permeability was observed in DNFB-sensitized and DNBS-challenged rats compared with control groups (P Ͻ 0.05, ANOVA). The DNBS challenge alone did not influence basal vascular leakage ( Figs. 1 and 2) .
In vitro small intestinal vascular permeability changes. The isolated fluorocarbon vascularly perfused small intestine, a preparation with physiological viability, was used to measure microvascular permeability changes from 15 to 60 min after in vitro DNBS challenge in detail using tracer molecules of different sizes (1.4-to 6-nm radius). FF400 (vrs) was used as the vascular tracer (Cl int,vrs ϭ 0 ml/min). The volume of distribution of FF400 (V d,vrs ϭ 1.45 Ϯ 0.05 ml) reflects the volume of the mesenteric vasculature between injection and sampling sites. Under control conditions (before in vitro DNBS challenge), the volume of distribution and the intrinsic clearance value of the diffusible tracer TRD70, a molecule that resembles plasma albumin in size, did not differ significantly from the vascu- (Table 1 and Fig. 3 ). Figure 3A and Table 1 show that in vitro DNBS challenge in sham-sensitized intestinal preparations did not significantly change the vascular permeability characteristics of all the tracers studied. In addition, DNBS challenge in isolated vascularly perfused small intestines of DNFB-sensitized rats did not induce changes of the volume of distribution of the vascular tracer FF400. However, intraluminal DNBS challenge in DNFB-sensitized preparations after 30-60 min significantly increased the volumes of distribution of the diffusible tracers TRD70, CBD10, and TMRD3 ( Table 1 ). The volumes of distribution of CBD10 and TMRD3 (V d,CBD10 vs. V d,TMRD3 , 3.07 Ϯ 0.23 vs. 3.13 Ϯ 0.20 ml, respectively) were two times the vascular volume (V d,vrs ϭ 1.59 Ϯ 0.03 ml) 30 min after the DNBS challenge. Figure 3B shows that 15 min after the DNBS challenge the vascular permeability for all diffusible tracers started to rise. The increase in vascular permeability peaked 30-60 min after the challenge. At t ϭ 15 min, the sensitized and challenged mesenteric vasculature was most permeable for the smallest tracer, TMRD3 (Fig. 3B ). However, 30-60 min after the DNBS challenge the clearance values for CBD10 and TMRD3 were not statistically different from each other (Fig.  3B) . The increase in permeability is seen earlier for the smaller molecules but is more extensive for the larger tracer (TRD70). Intraluminal DNFB challenge did not have an effect on the basal vascular pressure (ϳ90 mmHg) in either sham-or DNFB-sensitized intestinal preparations (data not shown). These results clearly demonstrate that vascular permeability changes early after mast cell activation can be detected using tracer molecules of varying sizes.
RMCP II release in serum. RMCP II was determined in serum samples from naive rats as well as from shamor DNFB-sensitized and DNBS-challenged rats. Basal RMCP II level in the serum of naive rats was ϳ100 ng RMCP II/ml serum. No differences were observed in RMCP II basal levels when the samples were obtained at t ϭ 15, 30, and 60 min. Figure 4 shows that DNBS challenge alone significantly enhanced the RMCP II levels 15 and 30 min after the challenge. However, in DNFB-sensitized and DNBS-challenged rats, a more profound fourfold increase in RMCP II serum levels was found, which was significantly different from levels of sham-sensitized and DNBS-challenged rats. This elevation of serum RMCP II returned to basal levels 120 min after the DNBS challenge ( Fig. 4) .
Effect of doxantrazole treatment on small intestinal DTH reaction. Mast cell stabilization induced by doxantrazole injection 30 min before and at time of challenge significantly inhibited the DTH-induced increase in small intestinal vascular permeability 30-60 min after the challenge (Fig. 1 ). In addition, analysis of RMCP II Table 1 http://ajpgi.physiology.org/ levels in the serum of DTH rats after doxantrazole pretreatment showed that this compound was effective in reducing the DTH-induced elevation of serum RMCP II (Fig. 5) .
. Extraction ratios and volumes of distribution of tracers in the rat isolated vascularly perfused small intestine
Effect of sensory neuropeptide depletion on small intestinal DTH reaction. Figure 2 shows that neuropeptide depletion completely inhibited the increase in small intestinal vascular permeability observed 30-60 min after challenge in DNFB-sensitized rats. No effects of capsaicin pretreatment were found on basal vascular leakage. Furthermore, depletion of neuropeptides completely abolished the DTH-induced increase in serum RMCP II levels observed 30 min after challenge (Fig. 6 ).
DISCUSSION
The aim of this study was to investigate the role of the mucosal mast cell in the early vascular permeabil-ity changes of dinitrobenzene-induced DTH reactions in the small intestine of the rat. DTH reactions are local T lymphocyte-dependent immune responses manifested by an inflammation (35) . It has been suggested that such a cell-mediated response plays an important role in the pathogenesis of IBD (13) . DTH reactions are characterized by an early (Ͻ2 h after the challenge) and a late component (24-48 h after the challenge). It is hypothesized that the early DTH response is induced by antigen-specific factors released by T lymphocytes within 1-2 days of sensitization, which arm mast cells systemically (26) . On local challenge, the T cell factor-armed mast cells release Results are means Ϯ SE for n ϭ 4 preparations. If no error bar is shown, SE was smaller than the symbol used. Under control conditions, there was a statistically significant difference between the vascular tracer FF400 and the diffusible tracers CBD10 and TMRD3 at all time points measured (P Ͻ 0.05, ANOVA). * P Ͻ 0.05, significant differences between control (before challenge) and after DNBS challenge (ANOVA). Fig. 4 . In vivo DTH-induced changes in levels of rat mast cell protease II (RMCP II) in rat serum 0-60 min after challenge. RMCP II serum levels are expressed as ng RMCP II/ml serum in shamsensitized rats (s) or DNFB-sensitized rats (r) after intragastric challenge with DNBS or in naive rats (k). Results are means Ϯ SE for n ϭ 5 rats/group. If no error bar is shown, SE was smaller than the symbol used. * P Ͻ 0.05 compared with control groups; # P Ͻ 0.05 compared with naive rats (ANOVA). vasoactive mediators, which cause a local increase in vascular permeability (27) . First, we have measured DTH-induced small intestinal vascular leakage within 2 h after the challenge. In vivo as well as in vitro a significant increase in small intestinal vascular permeability was found 30-60 min after DNBS challenge of DNFB-sensitized rats. Experiments with isolated vascularly perfused small intestines of DNFB-sensitized rats revealed that the DTH-induced increase of vasopermeability had already started 15 min after the DNBS challenge. Because the volume of distribution of the vascular tracer (FF400) did not change during the DTH reaction, it can be concluded that the DTH reaction does not give a greater exchange surface by opening up capillaries ( Table 1 ). These in vitro results clearly suggest that changes in vascular peremability, expressed as Cl int,i , can be detected using tracer molecules of varying sizes, although it cannot be formally excluded that changes in Cl int,i [or the permeabilitysurface area (PS) product] are the result of changes in available surface area rather than changes in permeability per se. It is unlikely that capillary recruitment and/or increased perfusion of mucosal vascular bed contributes significantly to an increase of PS product. Furthermore, it has been shown previously (19) that diffusion limitation, rather than flow limitation, applies to the tracers used.
Our findings are consistent with the early vascular permeability changes in the skin DTH reaction to picryl chloride described by Van Loveren and co-workers (35) and in the intestinal helminth infections described by Parmentier and co-workers (26) . Furthermore, it was demonstrated that mice intravenously injected with purified T cell factor developed an antigen-specific early cutaneous response after local challenge (4) .
There are several lines of evidence that favor a role for the mast cell in the early phase of DTH reactions. First, the reactions are elicited preferentially at sites enriched in mast cells, such as the intestinal tract, lung, buccal mucosa, and skin (1, 9, 25) . The release of the mast cell mediator serotonin during contact sensitization in the skin, early after the challenge, has been reported (14, 16, 35) . This vasoactive amine can act locally by increasing vascular permeability and inducing vasodilatation, thereby facilitating cellular infiltration (2, 4) . In addition, corticosteroid-induced mucosal mast cell depletion and treatment with mast cell stabilizers or serotonin antagonists suppressed DTH reaction in the skin and small intestine of the mouse and the rat (2, 4, 14) . Defective DTH responses have been observed in strains of mast cell-deficient mice (4, 23) . However, no reports have described direct assessment of mast cell activation during the early events of DTH reactions in the small intestine. In this study, we have monitored in vivo mucosal mast cell activation up to 120 min after the challenge by measurement of RMCP II. RMCP II is a protease specific for intestinal mucosal mast cells that appears in the serum of rats after mast cell degranulation (24) . Our results demonstrate that mucosal mast cells are activated 15-30 min after DNBS challenge in DNFB-sensitized rats. This mucosal mast cell activation slightly preceded the DTHinduced small intestinal vascular leakage changes found in vivo 30-60 min after the challenge. It even suggests that the DNBS challenge alone has a direct irritating effect on intestinal mucosal mast cells, because of the small rise in RMCP II found in sham-sensitized animals. This DNBS-induced mucosal mast cell activation was not accompanied by changes in vascular permeability in the small intestine after only DNBS challenge. It can be concluded that a more profound mucosal mast cell activation is necessary to result in an increase in vascular permeability.
To further investigate the role of the mucosal mast cell in the early component of small intestinal DTH reactions, rats were pretreated before the challenge with the mast cell stabilizer doxantrazole. This compound is able to prevent antigen-induced histamine release from gut-associated mucosal mast cells and to protect sensitized rats against ovalbumin-induced anaphylactic reactions (5, 28) . We have found that doxantrazole pretreatment inhibited the DTH-induced increase in small intestinal vascular permeability and RMCP II elevation in the serum. This is consistent with an important initiating role of the mucosal mast cell in the onset of dinitrobenzene-induced DTH reactions in the small intestine of the rat.
Few investigators have examined the role of sensory neuropeptides in DTH reactions. The close association of sensory nerves with mucosal mast cells and lymphocytes found in the gastrointestinal tract and the relevant biological actions suggest a possible function for neuropeptides in DTH reactions (3, 8, (32) (33) (34) . Substance P induces mediator release from different mast cell types in vitro (5) . The observation of release of airway mast cell mediators in vivo by substance P and . RMCP II serum levels are expressed as ng RMCP II/ml serum after intragastric challenge with DNBS in sham-sensitized, vehicle-treated (s) or capsaicin-treated (q) rats or DNFB-sensitized, vehicle-treated (r) or capsaicin-treated (p) rats. Results are means Ϯ SE for n ϭ 5 rats/group. If no error bar is shown, SE was smaller than the symbol used. * P Ͻ 0.05 compared with control groups; and # P Ͻ 0.05 compared with vehicle-treated animals (ANOVA). neurokinin A supports the growing belief that mast cells are under nervous control (12) . In this study, it was demonstrated that depletion of neuropeptides from sensory nerves by neonatal pretreatment with capsaicin resulted in significant inhibition of the early vascular leakage DTH response as well as in reduced mucosal mast cell activation. These results confirm the inhibitory effects of neuropeptide depletion and blockade of the neurokinin-1 receptor observed on dinitrobenzene-induced small intestinal DTH reaction in the mouse (17) . However, it is unclear whether sensory neuropeptides act directly on the mucosal mast cell in the DTH reaction or indirectly on T cell factorproducing lymphocytes. The tachykinins substance P and neurokinin A predominantly stimulate the proliferation, migration, and activation of lymphocytes (32, 33) , whereas vasoactive intestinal peptide, calcitonin generelated peptide, and somatostatin have inhibitory activities (32) . In addition, receptors for tachykinins have been found on lymphocytes (7) . Thus neuropeptide depletion could result in a direct inhibition of DTHinduced mucosal mast cell activation or in an inhibition of proliferation and activation of T cell factor-producing lymphocytes, which in turn will lead to less T cell factor-armed mast cells. Neonatal treatment with capsaicin could also affect the number of mucosal mast cells in the small intestine. Recently, Gottwald and colleagues (11) have demonstrated that 3 mo after neonatal capsaicin administration 28% fewer intestinal mucosal mast cells were found in treated rat jejunum compared with littermate controls. In this study, the rats were used at the age of 7-8 wk. It is not likely that at this age neonatal capsaicin pretreatment results in a complete depletion of intestinal mucosal mast cells and that the effects of this treatment found on DTHinduced vascular permeability changes and mucosal mast cell activation are only the result of a lowering of the number of mast cells.
In conclusion, the results of this study are consistent with an important role of the mucosal mast cell in the early vascular events in the dinitrobenzene-induced DTH reaction in the small intestine of the rat. In addition, we have demonstrated an interaction between sensory nerves and mucosal mast cell activation during the initiation phase of the small intestinal DTH response.
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